Long-Term Follow Up Shows No Overall Survival Difference With PARP Inhibitor Maintenance Therapy in Ovarian Cancer

First post and replies  | Last post by johan, 7 months ago

Cryptotanshinone Inhibits Ovarian Tumor Growth and Metastasis by Degrading c-Myc and Attenuating the FAK Pathway

First post and replies  | Last post by johan, 1 year ago

Stephenson Cancer Center Launches Historic Trial for Cancer Drug Developed in Oklahoma

First post and replies  | Last post by johan, 1 year ago

Beta-Caryophyllene Suppresses Ovarian Cancer Proliferation by Inducing Cell Cycle Arrest and Apoptosis

First post and replies  | Last post by johan, 2 years ago

Predicting master transcription factors from pan-cancer expression data

First post and replies  | Last post by johan, 2 years ago

Ascites Fluid - Need help

First post and replies  | Last post by Anil Khanna, 2 years ago

A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study

First post and replies  | Last post by Daniel, 3 years ago

Combination of Paclitaxel , Drugs and Supplements

First post and replies  | Last post by Daniel, 3 years ago

Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

First post and replies  | Last post by Daniel, 3 years ago

A list of clinical trials for platinum-resistant recurrent ovarian cancer

First post and replies  | Last post by Daniel, 3 years ago

Mebendazole --- Potential Treatment & Maintenance of Ovarian Cancer

First post and replies  | Last post by Kimster, 3 years ago

Identifying drugs that target ovarian cancer tumor initiating cells

First post and replies  | Last post by Kuldeep Choudhary, 3 years ago

Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term Mistletoe extract treatment

First post and replies  | Last post by johan, 3 years ago

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models

First post and replies  | Last post by Daniel, 4 years ago

Metformin may help prevent ovarian cancer

First post and replies  | Last post by Daniel, 4 years ago

Surgery for Recurrent Ovarian Cancer Does Not Improve Survival

First post and replies  | Last post by johan, 4 years ago

Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells

First post and replies  | Last post by Daniel, 4 years ago

Immunotherapy improves prognosis for women with recurrent ovarian cancer in clinical trial

First post and replies  | Last post by johan, 5 years ago

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer

First post and replies  | Last post by Daniel, 5 years ago

Endometrial Cancer Treatment

First post and replies  | Last post by Daniel, 5 years ago